200 related articles for article (PubMed ID: 31115928)
41. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
42. Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity.
Safavi M; Ashtari A; Khalili F; Mirfazli SS; Saeedi M; Ardestani SK; Rashidi Ranjbar P; Barazandeh Tehrani M; Larijani B; Mahdavi M
Chem Biol Drug Des; 2018 Jul; 92(1):1373-1381. PubMed ID: 29637699
[TBL] [Abstract][Full Text] [Related]
43. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
44. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
Tantak MP; Klingler L; Arun V; Kumar A; Sadana R; Kumar D
Eur J Med Chem; 2017 Aug; 136():184-194. PubMed ID: 28494255
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide-hydrazone and carboxamide moiety.
He H; Wang X; Shi L; Yin W; Yang Z; He H; Liang Y
Bioorg Med Chem Lett; 2016 Jul; 26(14):3263-3270. PubMed ID: 27262600
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
[TBL] [Abstract][Full Text] [Related]
49. Rational design, synthesis and anti-proliferative evaluation of novel benzosuberone tethered with hydrazide-hydrazones.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Guguloth V; Polepally S; Jain N
Bioorg Med Chem Lett; 2014 Nov; 24(21):5041-4. PubMed ID: 25264072
[TBL] [Abstract][Full Text] [Related]
50. Novel hydrazide-hydrazone and amide substituted coumarin derivatives: Synthesis, cytotoxicity screening, microarray, radiolabeling and in vivo pharmacokinetic studies.
Nasr T; Bondock S; Rashed HM; Fayad W; Youns M; Sakr TM
Eur J Med Chem; 2018 May; 151():723-739. PubMed ID: 29665526
[TBL] [Abstract][Full Text] [Related]
51. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells.
Liu WY; Li HY; Zhao BX; Shin DS; Lian S; Miao JY
Carbohydr Res; 2009 Jul; 344(11):1270-5. PubMed ID: 19527904
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
55. Naphthoquinone-based Hydrazone Hybrids: Synthesis and Potent Activity Against Cancer Cell Lines.
Guimaráes DG; de Assis Gonsalves A; Rolim LA; Araújo EC; Dos Anjos Santos VL; Silva MFS; de Cássia Evangelista de Oliveira F; da Costa MP; Pessoa C; Fonseca Goulart MO; Silva TL; Santos DC; Araújo CRM
Med Chem; 2021; 17(9):945-955. PubMed ID: 32807066
[TBL] [Abstract][Full Text] [Related]
56. Time-dependent AI-Modeling of the anticancer efficacy of synthesized gallic acid analogues.
Sherin L; Sohail A; Shujaat S
Comput Biol Chem; 2019 Apr; 79():137-146. PubMed ID: 30818108
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, Antitumor Activity and Molecular Docking Studies on Seven Novel Thiazacridine Derivatives.
Almeida ML; Viana DCF; da Costa VCM; Dos Santos FA; Pereira MC; Pitta MGR; de Melo Rêgo MJB; Pitta IR; Pitta MGR
Comb Chem High Throughput Screen; 2020; 23(5):359-368. PubMed ID: 32189590
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
Mandalapu D; Saini KS; Gupta S; Sharma V; Yaseen Malik M; Chaturvedi S; Bala V; Hamidullah ; Thakur S; Maikhuri JP; Wahajuddin M; Konwar R; Gupta G; Sharma VL
Bioorg Med Chem Lett; 2016 Sep; 26(17):4223-32. PubMed ID: 27496212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]